Dana Teller, MD
Obstetrics & Gynecology · San Diego, CANPI 1295154607
Payments from drug & device makers
Across 125 payments — averaging $20.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Celularity Inc.$357
- Astellas Pharma US Inc$260
- Mayne Pharma Commercial LLC$228
- Coopersurgical, Inc.$169
- AbbVie$157
- Biogen$137
- plus $1K from 31 others
What the payments were for
- Speaking & faculty fees$30012%
- Food & beverage$2,23386%
- Education$753%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Celularity Inc. | 5 | $357 |
| Astellas Pharma US Inc | 10 | $260 |
| Mayne Pharma Commercial LLC | 13 | $228 |
| Coopersurgical, Inc. | 9 | $169 |
| AbbVie(2 entities) | 12 | $157 |
| Biogen | 6 | $137 |
| Hologic Sales And Service, LLC | 6 | $131 |
| Amgen | 5 | $102 |
| Exact Sciences | 5 | $95 |
| Bayer | 4 | $86 |
| Channel Medsystems, Inc. | 2 | $86 |
| Organon | 4 | $68 |
| Pfizer | 2 | $66 |
| Lupin Inc. | 4 | $57 |
| Myovant Sciences Inc. | 3 | $55 |
| Sumitomo Pharma America, Inc. | 3 | $47 |
| Avion Pharmaceuticals | 3 | $44 |
| Shield Therapeutics Inc | 2 | $44 |
| Exeltis, USA Inc. | 3 | $43 |
| Aspira Women's Health Inc | 2 | $37 |
| Daiichi Sankyo Inc. | 2 | $35 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $35 |
| Johnson & Johnson | 1 | $32 |
| Millicent US Inc | 2 | $32 |
| Evofem Biosciences, Inc. | 2 | $28 |
| Merck | 2 | $27 |
| BD | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
| Agile Therapeutics, Inc. | 1 | $15 |
| Seqirus USA Inc | 1 | $15 |
| Therapeuticsmd, Inc. | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
| Innovation Technologies Inc | 1 | $14 |
| Mylan Pharmaceuticals Inc. | 1 | $13 |
| AstraZeneca | 1 | $12 |
| Meditrina | 1 | $5 |
How this compares
$2,608 in reported general payments places this provider in the 80th percentile of 3,784 obstetrics & gynecology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other obstetrics & gynecology in San Diego
- Rovena ReaganSan Diego$1.7M
- Denis TarakjianSan Diego$973K
- Sheila ModySan Diego$465K
- Antoinette Marengo BarbickSan Diego$141K
- Peyman BanooniBeverly Hills$9.2M
- Vellore BhupathyWhittier$4.3M
- Edwin RamirezOxnard$3.5M
- Nam TranSan Francisco$3M
- Dmitriy RomanenkoSouth Gate$2.7M
- Anita NelsonTorrance$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.